Novel small molecules for the treatment of infections caused byCandida albicans: a patent review (2002 – 2010)

Antimicrobial peptides: General overview and clinical implications in human health and disease

(2010) Eduardo Guaní-Guerra et al.   CLINICAL IMMUNOLOGY

Fungal infections in oncology patients: update on epidemiology, prevention, and treatment

(2010) Kieren A Marr   CURRENT OPINION IN ONCOLOGY

Identification of Inhibitors of Drug-ResistantCandida albicansStrains from a Library of Bicyclic Peptidomimetic Compounds

(2010) Andrea Trabocchi et al.   JOURNAL OF MEDICINAL CHEMISTRY

An insight into the antifungal pipeline: selected new molecules and beyond

(2010) Luis Ostrosky-Zeichner et al.   NATURE REVIEWS DRUG DISCOVERY

Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: Implications for the design of antifungal agents

(2010) Cele Abad-Zapatero et al.   PROTEIN SCIENCE

Pharmacokinetics of Nikkomycin Z after Single Rising Oral Doses

(2009) D. E. Nix et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

FR290581, a novel sordarin derivative: Synthesis and antifungal activity

(2009) Tadaatsu Hanadate et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Targeting virulence: A new paradigm for antifungals

(2009) Katharina Gauwerky et al.   DRUG DISCOVERY TODAY

Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics

(2009) Suk Hyun Jung et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B

(2008) H. Sandovsky-Losica et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY